AU9017198A - Treatment of equine protozoan myeloencephalitis using triazinediones - Google Patents

Treatment of equine protozoan myeloencephalitis using triazinediones

Info

Publication number
AU9017198A
AU9017198A AU90171/98A AU9017198A AU9017198A AU 9017198 A AU9017198 A AU 9017198A AU 90171/98 A AU90171/98 A AU 90171/98A AU 9017198 A AU9017198 A AU 9017198A AU 9017198 A AU9017198 A AU 9017198A
Authority
AU
Australia
Prior art keywords
triazinediones
treatment
myeloencephalitis
equine
equine protozoan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90171/98A
Inventor
Meri Charmyne Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mortar and Pestle Veterinary Pharmacy Inc
Original Assignee
Mortar and Pestle Veterinary Pharmacy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mortar and Pestle Veterinary Pharmacy Inc filed Critical Mortar and Pestle Veterinary Pharmacy Inc
Publication of AU9017198A publication Critical patent/AU9017198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU90171/98A 1998-07-27 1998-08-12 Treatment of equine protozoan myeloencephalitis using triazinediones Abandoned AU9017198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12237598A 1998-07-27 1998-07-27
US09122375 1998-07-27
PCT/US1998/016649 WO2000006172A1 (en) 1998-07-27 1998-08-12 Treatment of equine protozoan myeloencephalitis using triazinediones

Publications (1)

Publication Number Publication Date
AU9017198A true AU9017198A (en) 2000-02-21

Family

ID=22402339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90171/98A Abandoned AU9017198A (en) 1998-07-27 1998-08-12 Treatment of equine protozoan myeloencephalitis using triazinediones

Country Status (2)

Country Link
AU (1) AU9017198A (en)
WO (1) WO2000006172A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631278A (en) * 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones

Also Published As

Publication number Publication date
WO2000006172A1 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
AU3891299A (en) Combination therapy for treatment of depression
AU3784999A (en) Methods for treatment of pain
AU3896900A (en) Treatment of pain
AU1697197A (en) Immunoconjugate for the treatment of aids
AU4229197A (en) Treatment of equine protozoal myeloencephalitis
AU3760900A (en) Treatment of menstrual function
AU2566201A (en) Compounds and methods for the treatment of pain
AU2420101A (en) Method and composition for the treatment of pain
AU9017198A (en) Treatment of equine protozoan myeloencephalitis using triazinediones
AU1931895A (en) Treatment of graft-versus-host disease
AU2619199A (en) Treatment of waxes
AU4598400A (en) Method of treatment
AUPP229598A0 (en) Treatment of sunburn
AU2026400A (en) Treatment of myelogenous leukemia
AU6112299A (en) Treatment of effluents
AU2420201A (en) Compounds and methods for the treatment of pain
AU4310397A (en) Treatment of waste
EP1143998A4 (en) Treatment of hypertension
AU5524399A (en) Inorgasmia treatment
PL346528A1 (en) Treatment of depression
AU5753599A (en) Treatment of fibres
AU2912199A (en) Treatment of sunburn
AUPQ421299A0 (en) Treatment of bone disorder
AUPP795298A0 (en) Method of treatment
AUPP363398A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase